论文信息 - Liposomal daunorubicin versus standard daunorubicin: long term follow‐up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia - 字舞流文

Liposomal daunorubicin versus standard daunorubicin: long term follow‐up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia

M. Baccarani | S. Iacobelli | M. Vignetti | F. Mandelli | R. Latagliata | G. Martinelli | M. Morselli | F. Di Raimondo | S. Amadori | P. Fazi | M. Pirrotta | M. Breccia | G. Alimena | F. Fabbiano | A. Candoni | F. Falzetti | A. Zaccaria | D. Mattei | C. Caramatti | M. Sborgia | Maria Teresa Pirrotta | Maria Teresa Pirrotta